Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

Journal: Nature

Published: 2019-07-17

DOI: 10.1038/s41586-019-1410-1

Affiliations: 21

Authors: 27

Go to article
Institutions Share
Department of Biomedicine Basel, Switzerland 0.26
Department of Internal Medicine II - Oncology, Hematology, Clinical Immunology, Rheumatology and Pulmology, Uni Tübingen, Germany 0.13
University Hospital Basel (USB), UB, Switzerland 0.09
Heidelberg Institute for Stem Cell Technologies and Experimental Medicine (HI-STEM gGmbH), Germany 0.06
DKFZ-ZMBH Alliance, Germany 0.06
DKTK Partner Site Tuebingen, Germany 0.06
Department of Internal Medicine V: Hematology, Oncology and Rheumatology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.05
Cluster of Excellence - Image-Guided and Functionally Instructed Tumor Therapies (iFIT), Uni Tübingen, Germany 0.04
Institute for Molecular Medicine (IMM), GU, Germany 0.04
Institute of Pathology and Neuropathology, Uni Tübingen, Germany 0.04
Division of Blood and Marrow Transplantation, UMN, United States of America (USA) 0.04
Institute of Medical Genetics and Pathology, UB, Switzerland 0.04
Beckman Research Institute, City of Hope, United States of America (USA) 0.02
University Medical Center Freiburg, Germany 0.02
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0.02
University Children's Hospital Basel (UKBB), Switzerland 0.02
German Consortium of Translational Cancer Research (DKTK), Germany 0.01
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, United States of America (USA) 0.01
Department of Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, United States of America (USA) 0.01